HIV trial scrapped; FDA: Gardasil safe and effective;

Vaccine Research

Government officials have scrapped plans for a major human trial of a new HIV vaccine, still convinced that there is considerable basic research work that needs to be done before going back into the clinic after the disastrous failure last year of a key Merck trial. Report

Emergent BioSolutions and Oxford University are teaming up to study a new TB vaccine. Story

Researchers from Maryland and South Carolina have developed a novel four-component vaccine that protects monkeys against all four strains of dengue virus and may potentially offer protection to the millions of humans at risk worldwide. Release

GeoVax Labs and France's Vivalis have agreed to link an experimental HIV vaccine with Vivalis' manufacturing technology. Report

AlphaVax announced today the initiation of a Chlamydia vaccine program based on its alphavirus vector platform technology. Release

Vaccine Market

Officials in Australia say that the new cervical cancer vaccine is so effective they expect to see deaths from the disease halved within two years. Story

UK officials, meanwhile, say they will extend the government's HPV vaccination campaign to 300,000 more girls. Report

After reviewing thousands of cases of adverse events related to Gardasil, FDA officials have confirmed that the drug is safe and effective. Report

An increase of nine percent in Prevnar sales helped Wyeth boost its quarterly revenue figures. Story

Suggested Articles

Pfizer and BioNTech followed supply pacts in the U.S. and U.K. with a new deal to deliver 120 million vaccines to Japan in the first half of 2021.

Sanofi's cost cuts are adding up, execs said in an update Wednesday. The company has trimmed nearly €1 billion in annual expenses so far in 2020.

Shingrix sales in the second quarter plummeted by half from first-quarter levels, and recovery of vaccination rates remains slow amid the pandemic.